Clinical Trials Directory

Trials / Unknown

UnknownNCT03939663

Role of Vaginal Misoprostol Prior to IUCD Insertion in Women Who Delivered Only by Elective Caesarean Section.

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
210 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

Role of vaginal misoprostol prior to IUCD insertion in women who delivered only by elective caesarean section.

Detailed description

Misoprostol ( 400mcg ) vaginally administrated 3 hours prior to IUCD insertion increases the ease and success of insertion and decrease associated pain among women who had delivered only by elective caesarean section.

Conditions

Interventions

TypeNameDescription
DRUGmisoprostolmisoprostol 2 tablets
DRUGPlacebostarch pills manufactured to mimic misoprostol 200 mg tablets

Timeline

Start date
2018-07-01
Primary completion
2019-07-01
Completion
2019-12-01
First posted
2019-05-07
Last updated
2019-05-07

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03939663. Inclusion in this directory is not an endorsement.